Gemma Tell‐Martí

771 total citations
28 papers, 402 citations indexed

About

Gemma Tell‐Martí is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Gemma Tell‐Martí has authored 28 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Molecular Biology and 12 papers in Cell Biology. Recurrent topics in Gemma Tell‐Martí's work include Cutaneous Melanoma Detection and Management (18 papers), melanin and skin pigmentation (11 papers) and Melanoma and MAPK Pathways (10 papers). Gemma Tell‐Martí is often cited by papers focused on Cutaneous Melanoma Detection and Management (18 papers), melanin and skin pigmentation (11 papers) and Melanoma and MAPK Pathways (10 papers). Gemma Tell‐Martí collaborates with scholars based in Spain, United States and United Kingdom. Gemma Tell‐Martí's co-authors include Susana Puig, Josep Malvehy, Joan Anton Puig‐Butillé, Célia Bádenas, Cristina Carrera, Paula Aguilera, Míriam Potrony, Àngels Fabra, Asunción Vicente and Marc Dabad and has published in prestigious journals such as Annals of Neurology, Annals of Oncology and International Journal of Cancer.

In The Last Decade

Gemma Tell‐Martí

28 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gemma Tell‐Martí Spain 11 234 218 115 74 48 28 402
Si‐Qi Chen China 8 308 1.3× 437 2.0× 96 0.8× 49 0.7× 16 0.3× 13 603
Michael Salmans United States 9 157 0.7× 294 1.3× 96 0.8× 38 0.5× 20 0.4× 10 499
Youngkyoung Lim South Korea 9 75 0.3× 148 0.7× 76 0.7× 30 0.4× 64 1.3× 34 328
Iraz T. Aydin United States 9 112 0.5× 321 1.5× 124 1.1× 38 0.5× 12 0.3× 13 409
Valerie J. Carpenter United States 9 162 0.7× 300 1.4× 32 0.3× 129 1.7× 14 0.3× 15 582
Julien Ackermann Switzerland 5 166 0.7× 404 1.9× 148 1.3× 93 1.3× 26 0.5× 5 496
Anda Huna France 14 183 0.8× 390 1.8× 162 1.4× 65 0.9× 13 0.3× 27 657
S.H. Kidson South Africa 14 63 0.3× 164 0.8× 164 1.4× 48 0.6× 44 0.9× 23 387
Kiyotaka Oshikawa Japan 9 197 0.8× 465 2.1× 69 0.6× 118 1.6× 6 0.1× 13 668
Michelle Dang United States 9 67 0.3× 161 0.7× 104 0.9× 46 0.6× 8 0.2× 10 301

Countries citing papers authored by Gemma Tell‐Martí

Since Specialization
Citations

This map shows the geographic impact of Gemma Tell‐Martí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma Tell‐Martí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma Tell‐Martí more than expected).

Fields of papers citing papers by Gemma Tell‐Martí

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma Tell‐Martí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma Tell‐Martí. The network helps show where Gemma Tell‐Martí may publish in the future.

Co-authorship network of co-authors of Gemma Tell‐Martí

This figure shows the co-authorship network connecting the top 25 collaborators of Gemma Tell‐Martí. A scholar is included among the top collaborators of Gemma Tell‐Martí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemma Tell‐Martí. Gemma Tell‐Martí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calbet‐Llopart, Neus, Marc Combalia, Míriam Potrony, et al.. (2022). Common genetic variants associated with melanoma risk or naevus count in patients with wildtype MC1R melanoma. British Journal of Dermatology. 187(5). 753–764. 5 indexed citations
2.
Podlipnik, Sebastián, Cristina Carrera, Míriam Potrony, et al.. (2022). Synchronous primary cutaneous melanomas: a descriptive study of their clinical features, histology, genetic background of the patients and clinical outcomes. Journal of the European Academy of Dermatology and Venereology. 36(12). 2364–2372. 4 indexed citations
3.
Vinyals, Antònia, Neus Calbet‐Llopart, Gemma Tell‐Martí, et al.. (2022). Oncogenic properties via MAPK signaling of the SOX5‐RAF1 fusion gene identified in a wild‐typeNRAS/BRAF giant congenital nevus. Pigment Cell & Melanoma Research. 35(4). 450–460. 2 indexed citations
4.
Potrony, Míriam, Gemma Tell‐Martí, Pol Giménez‐Xavier, et al.. (2021). DNA Repair and Immune Response Pathways Are Deregulated in Melanocyte-Keratinocyte Co-cultures Derived From the Healthy Skin of Familial Melanoma Patients. Frontiers in Medicine. 8. 692341–692341. 1 indexed citations
5.
Tell‐Martí, Gemma, Neus Calbet‐Llopart, Alicia Barreiro, et al.. (2020). Influence of germline genetic variants on dermoscopic features of melanoma. Pigment Cell & Melanoma Research. 34(3). 618–628. 2 indexed citations
6.
Calbet‐Llopart, Neus, Gemma Tell‐Martí, Míriam Potrony, et al.. (2020). Melanocortin‐1 receptor ( MC1R ) genotypes do not correlate with size in two cohorts of medium‐to‐giant congenital melanocytic nevi. Pigment Cell & Melanoma Research. 33(5). 685–694. 6 indexed citations
7.
Calbet‐Llopart, Neus, Míriam Potrony, Gemma Tell‐Martí, et al.. (2019). Detection of cell‐free circulating BRAF V 600E by droplet digital polymerase chain reaction in patients with and without melanoma under dermatological surveillance. British Journal of Dermatology. 182(2). 382–389. 7 indexed citations
8.
Selim, M. Angélica, Yan Peng, Gemma Tell‐Martí, et al.. (2018). Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas. Human Pathology. 73. 176–183. 20 indexed citations
9.
Tell‐Martí, Gemma, Marc Dabad, Cristina Carrera, et al.. (2018). Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations. Journal of Investigative Dermatology. 139(4). 900–908. 60 indexed citations
10.
Potrony, Míriam, Joan Anton Puig‐Butillé, James M. Farnham, et al.. (2018). Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11q. European Journal of Human Genetics. 26(8). 1188–1193. 3 indexed citations
11.
Tell‐Martí, Gemma, Míriam Potrony, Célia Bádenas, et al.. (2017). Melanocortin 1 receptor (MC1R) polymorphisms’ influence on size and dermoscopic features of nevi. Pigment Cell & Melanoma Research. 31(1). 39–50. 17 indexed citations
12.
Rabbie, Roy, Mamunur Rashid, Ana Arance, et al.. (2017). Genomic analysis and clinical management of adolescent cutaneous melanoma. Pigment Cell & Melanoma Research. 30(3). 307–316. 10 indexed citations
13.
Puig‐Butillé, Joan Anton, Antònia Vinyals, Paula Aguilera, et al.. (2017). AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy. Journal of Investigative Dermatology. 137(6). 1297–1310. 44 indexed citations
14.
Potrony, Míriam, Célia Bádenas, Paula Aguilera, et al.. (2016). Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas. Clinical Chemistry and Laboratory Medicine (CCLM). 54(11). 1733–1738. 1 indexed citations
15.
Puig‐Butillé, Joan Anton, Pol Giménez‐Xavier, Alessia Visconti, et al.. (2016). Genomic expression differences between cutaneous cells from red hair color individuals and black hair color individuals based on bioinformatic analysis. Oncotarget. 8(7). 11589–11599. 6 indexed citations
16.
Carrera, Cristina, Joan Anton Puig‐Butillé, Gemma Tell‐Martí, et al.. (2015). MultipleBRAFWild-Type Melanomas During Dabrafenib Treatment for MetastaticBRAF-Mutant Melanoma. JAMA Dermatology. 151(5). 544–544. 10 indexed citations
17.
Potrony, Míriam, Joan Anton Puig‐Butillé, Paula Aguilera, et al.. (2015). Prevalence ofMITFp.E318K in Patients With Melanoma Independent of the Presence ofCDKN2ACausative Mutations. JAMA Dermatology. 152(4). 405–405. 35 indexed citations
18.
Tell‐Martí, Gemma, Célia Bádenas, Mílvia M. S. S. Enokihara, et al.. (2015). Mutational status of naevus-associated melanomas. British Journal of Dermatology. 173(3). 671–680. 28 indexed citations
19.
Tell‐Martí, Gemma, Joan Anton Puig‐Butillé, Míriam Potrony, et al.. (2015). The MC1R melanoma risk variant p.R160W is associated with Parkinson disease. Annals of Neurology. 77(5). 889–894. 36 indexed citations
20.
Puig‐Butillé, Joan Anton, M.J. Escámez, Francisco García‐García, et al.. (2013). Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer. Oncotarget. 5(6). 1439–1451. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026